外源性苯甲酰牙子碱代谢酶的首次发现与合理化设计及其催化机制研究
批准号:
82073749
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
陈侠斌
依托单位:
学科分类:
生物技术药物
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
陈侠斌
中文摘要
苯甲酰芽子碱(BZE)是可卡因的主要有毒代谢物,体内半衰期长,主要负责可卡因的长期毒性。内源性丁酰胆碱酯酶是目前唯一报道的BZE代谢酶(BZEase),可降解BZE为无生物活性的分子,但催化活性低、糖基化修饰复杂、重组表达困难。因此发现和改造新型BZEase,实现催化活性高、表达经济高效,对开发可卡因酶法解毒治疗具有重要价值。课题组首次发现细菌来源且能高效表达的可卡因酯酶(CocE)能催化BZE苯酯水解,初步改造获得V116K突变体,对BZE的催化效率(kcat/KM)提高了64倍。本项目拟采用结构生物学和计算机模拟方法,构建准确的BZEase-BZE结合模型,深入阐明BZEase的催化机理,并确定影响限速步过渡态结构稳定性的因素。继而运用计算机辅助设计和实验验证相结合的策略,进一步合理化设计改造BZEase,以获得更高活性BZEase突变体,为可卡因的彻底解毒治疗提供新的候选药物。
英文摘要
Benzoylecgonine (BZE) is the major toxic metabolite of cocaine, and is responsible for the long-term cocaine-induced toxicity due to its long residence time in human. Endogenous butyrylcholinesterase is currently recognized as the only BZE-metabolizing enzyme (BZEase), which can degrade BZE into biologically inactive metabolites. However, its low catalytic activity and the great challenge to efficiently and economically produce recombinant BChE limit its potential application as an BZEase. Hence, it is critical to discover new BZE-metabolizing enzymes for treatment of cocaine toxicity, an effort to identify new promising biopharmaceuticals that are highly active in BZE hydrolysis and cost-effective in production. Our preliminary data demonstrated for the first time that bacterial cocaine esterase (CocE) can catalyze the hydrolysis of BZE at benzoyl ester group. However, the catalytic efficiency of wild-type CocE against BZE is too low to effectively metabolize BZE to completely eliminate its toxicity. The encouraging mutant V116K we discovered in the first round showed 64-fold improved catalytic efficiency(kcat/KM), which demonstrates the feasibility of our approach. Therefore, the proposed investigation is intended to build an accurate BZEase-BZE binding model, uncover the detailed mechanism for BZEase-catalyzed hydrolysis of BZE, and determine the factors that could affect the stability of the rate-determining transition state of the enzymatic reaction. In light of the aforementioned insights, high-activity mutants of BZEase could be rationally designed and discovered using novel integrated computational-experimental approach. An effort to discover new BZEase mutants with highly improved catalytic activity against BZE could led to the discovery of potential therapeutic agents for complete elimination of cocaine’s toxicity.
本项目的主要目标为开发高效、安全、成本低廉的候选酶药物,用于可卡因的彻底解毒治疗,降低可卡因滥用对世界范围内人民健康和社会安定的巨大威胁。我们通过动力学模拟结合实验验证,首次发现可降解可卡因主要有毒代谢物苯甲酰芽子碱(Benzoylecgonine,BZE)的外源性水解酶--细菌可卡因酯酶(Cocaine Esterase,CocE),可用大肠杆菌系统高效表达,成本低廉。我们利用分子动力学和自由能模拟,首次阐明CocE水解BZE的反应机理,确定了反应限速步骤,在此基础上开发了快速准确的基于反应物态的酶设计方法RED,通过迭代优化,设计CocE六重突变体A51L/V116K/T172R/G173Q/L196C/I301C(命名为BZEase2),显著提升其催化BZE水解效率427倍。体内酶活性实验表明,单次常规剂量的BZEase2(1 mg/kg,IV)可以在两分钟内消除几乎所有的 BZE,快速消除大鼠体内BZE毒性,且作为外源性酶其自身体内半衰期短,可在发挥作用后快速在体内代谢清除,减少潜在的超敏和免疫交叉反应,是一个理想的可卡因彻底解毒候选酶。我们首次解析了CocE与BZE水解产物苯甲酸(BA)的复合物晶体结构,为CocE进一步改造提供了准确的酶与底物结合模型。在此基础上我们进一步改造BZEase2,其Q55D突变体(A51L/Q55D/V116K/T172R/G173Q/L196C/I301C)提高了对可卡因催化效率7.3倍,对BZE的催化效率同时提高了1.5倍,可用于可卡因的彻底戒毒。我们的项目为全面消除可卡因的毒性提供了一个理想的候选酶药物,对解决全球可卡因滥用问题具有重要意义。并且我们的酶改造思路和方法还可用于其他水解酶的设计,具有普适意义。
苯甲酰芽子碱水解酶的设计制备及活性评价
-
批准号:81803417
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2018
-
负责人:陈侠斌
-
依托单位:
国内基金
海外基金